Artículos del autor

solaci

Structural heart disease

Clinical Implications of the Presence of HALT in TAVR Patients: 5-Year Follow-Up

The duration of percutaneous aortic valve implants can be increasingly observed over time, regardless of their corresponding...
solaci -
Institutional News

NEW DEADLINE | MIL train more MIL – Training Scholarship Program for Latin American Interventional Women in Structural Pathology

The MIL-SOLACI Group, with the support of Medtronic, is awarding 10 training scholarships in structural pathology for...
solaci -
Structural heart disease

Is the PASCAL Device Effective against MitraClip?

Mitral regurgitation (MR) is the most common valvulopathy and full medical treatment at maximal tolerated doses has...
solaci -
Chronic Ischemic cardiopathy

We Should Treat Significant Stable CAD in Patients Undergoing TAVR

Aortic stenosis is associated to significant coronary artery disease (CAD) in nearly 50% of cases.  When we decide...
solaci -
Chronic Ischemic cardiopathy

Combined Calcified Lesion Preparation Strategy

Stent sub-expansion in coronary territory has been identified as one of the major predictors of stent failure...
solaci -
Antithrombotic Anticoagulants

Is Clopidogrel Monotherapy Safe After a Month of Dual Antiplatelet Therapy in Diabetic Patients?

Currently, many randomized studies have suggested that short-term dual antiplatelet therapy (DAPT) followed by monotherapy reduces bleeding...
solaci -
Antiplatelet

Ticagrelor or Prasugrel Post-PCI in Daily Practice Patients

The ISAR-REACT 5 showed a significant reduction in the composite outcome of death, acute myocardial infarction (AMI),...
solaci -
Structural heart disease

Is There any Difference between Modern Valves and Self and Balloon Expandable Valves?

At present TAVR is a valid alternative to treat different risk groups of patients with severe aortic...
solaci -